Neutralase heparinase I enzyme: Will begin Phase II trials

Ibex Technologies Inc. (TSE:IBT), Montreal, Quebec Product: Neutralase heparinase I enzyme Indication: Reverse heparin after coronary artery bypass graft surgery Status: Will begin Phase II trials in ...